BiOasis Technologies Inc. is developing drug delivery technologies to transport therapeutics across the blood-brain barrier (BBB) to treat central nervous system diseases. Its lead product Transcend is a natural human protein that acts as a "Trojan horse" to transport drugs into the brain. BiOasis is also developing Transcendpep, a peptide derived from Transcend, which offers improved brain penetration. The company has multiple collaboration and licensing agreements with large pharmaceutical companies to develop drug conjugates using its BBB delivery technologies. BiOasis aims to establish partnerships to advance its internal programs and expand its intellectual property portfolio.
A brain tumor is an abnormal growth of cells within the brain or the central spinal canal that can be cancerous or benign. Learn more about brain tumors and how Rush Radiosurgery's noninvasive treatment may work for you.
This document provides information about ASINEX Medkhim, a private company developing innovative medicines to treat orphan and serious diseases. The company is working on a project to develop drugs for brain cancer and brain metastases, which represent a major global health problem with no effective treatments currently available. The company has developed novel patent-pending kinase inhibitors that are able to cross the blood-brain barrier and show antitumor efficacy in animal models. They are seeking $3 million in additional funding to advance the drug candidates through preclinical development and $4-5 million to initiate clinical trials.
biOasis Technologies, Inc. Presentation - October 2014graemedick
This document discusses biOasis Technologies Inc., a company developing a drug delivery platform to transport therapeutics across the blood-brain barrier (BBB) for treating central nervous system diseases. The platform utilizes melanotransferrin (MTf), a human protein that naturally transports iron into the brain. BiOasis has discovered a peptide within MTf, called MTfp, that offers improved brain penetration. Studies show MTf and MTfp conjugated to various compounds, including antibodies, enzymes and chemotherapy drugs, significantly increase transport into the brain compared to the compounds alone. BiOasis is working to validate and expand this technology with the goal of developing treatments for diseases like Alzheimer's, lysosomal storage disorders and brain cancer.
Visa Inc. held its 2014 Annual Meeting of Stockholders on January 29, 2014. The meeting was chaired by Robert W. Matschullat and included presentations from Charles W. Scharf, the company's Chief Executive Officer, and Ariela St. Pierre, the Corporate Secretary. In fiscal year 2013, Visa Inc. generated $11.8 billion in net operating revenue, $7.59 in diluted earnings per share, and $4.3 trillion in global payments volume. For fiscal year 2014, the company expects low double-digit net revenue growth, an operating margin in the low 60s, and mid-to-high teens growth in diluted class A common stock earnings per share.
This investor presentation from Joey New York describes the company's focus on building beauty, wellness, and lifestyle businesses. It highlights the company's recent acquisition of The Labb Aesthetic Beauty Bar, which operates luxury medical spas offering FDA-approved injectable treatments like Botox and fillers. The presentation outlines the large and growing market opportunity in facial aesthetics, details The Labb's current locations and plans for rapid expansion, and reviews the attractive chair-level economics of the business model.
This investor presentation from Joey New York discusses the company's acquisition of The Labb Aesthetic Beauty Bar (LABB), a luxury medical spa focused on injectable aesthetic services. The presentation outlines LABB's business model, market opportunity in the growing $9.2 billion facial aesthetics industry, and plans to rapidly expand the LABB brand to 20 locations by 2018. Financial projections estimate each LABB chair can generate $2-5 million in annual revenue given industry-leading margins and repeat customer rates.
This investor presentation provides an overview of Osisko Development Corp.'s plans to revive historical mining camps in North America. It discusses the results of a feasibility study for the Cariboo gold project in central British Columbia, which indicates it could be a large, long-lived, profitable mine. However, it notes the study includes various assumptions, uncertainties and risks that could materially affect results. It also discusses exploration results for the Trixie area that aim to expand resources but may not accurately predict mineralization. The presentation cautions investors that actual results may differ from expectations.
From idea to IPO: How an ISV can achieve growth and success within the Salesforce ecosystem
On July 14th, 2020, nCino rang the opening bell and became a publicly-traded company. To both thrive as a Salesforce ISV and accomplish something as impressive as an IPO requires getting many things right.
Brian Walsh, CodeScience CEO, sits down with Trisha Price, nCino CPO, to have an open conversation of how nCino got things right and share what ISVs can do today to set themselves up for success.
In this webinar, you’ll learn:
- How your customer needs can drive your product strategy
- Why company culture is a core differentiator and a lever of success for nCino
- What it takes to create meaningful relationships at Salesforce as an ISV
Don’t miss this opportunity to learn how you can create a business on Salesforce that thrives.
A brain tumor is an abnormal growth of cells within the brain or the central spinal canal that can be cancerous or benign. Learn more about brain tumors and how Rush Radiosurgery's noninvasive treatment may work for you.
This document provides information about ASINEX Medkhim, a private company developing innovative medicines to treat orphan and serious diseases. The company is working on a project to develop drugs for brain cancer and brain metastases, which represent a major global health problem with no effective treatments currently available. The company has developed novel patent-pending kinase inhibitors that are able to cross the blood-brain barrier and show antitumor efficacy in animal models. They are seeking $3 million in additional funding to advance the drug candidates through preclinical development and $4-5 million to initiate clinical trials.
biOasis Technologies, Inc. Presentation - October 2014graemedick
This document discusses biOasis Technologies Inc., a company developing a drug delivery platform to transport therapeutics across the blood-brain barrier (BBB) for treating central nervous system diseases. The platform utilizes melanotransferrin (MTf), a human protein that naturally transports iron into the brain. BiOasis has discovered a peptide within MTf, called MTfp, that offers improved brain penetration. Studies show MTf and MTfp conjugated to various compounds, including antibodies, enzymes and chemotherapy drugs, significantly increase transport into the brain compared to the compounds alone. BiOasis is working to validate and expand this technology with the goal of developing treatments for diseases like Alzheimer's, lysosomal storage disorders and brain cancer.
Visa Inc. held its 2014 Annual Meeting of Stockholders on January 29, 2014. The meeting was chaired by Robert W. Matschullat and included presentations from Charles W. Scharf, the company's Chief Executive Officer, and Ariela St. Pierre, the Corporate Secretary. In fiscal year 2013, Visa Inc. generated $11.8 billion in net operating revenue, $7.59 in diluted earnings per share, and $4.3 trillion in global payments volume. For fiscal year 2014, the company expects low double-digit net revenue growth, an operating margin in the low 60s, and mid-to-high teens growth in diluted class A common stock earnings per share.
This investor presentation from Joey New York describes the company's focus on building beauty, wellness, and lifestyle businesses. It highlights the company's recent acquisition of The Labb Aesthetic Beauty Bar, which operates luxury medical spas offering FDA-approved injectable treatments like Botox and fillers. The presentation outlines the large and growing market opportunity in facial aesthetics, details The Labb's current locations and plans for rapid expansion, and reviews the attractive chair-level economics of the business model.
This investor presentation from Joey New York discusses the company's acquisition of The Labb Aesthetic Beauty Bar (LABB), a luxury medical spa focused on injectable aesthetic services. The presentation outlines LABB's business model, market opportunity in the growing $9.2 billion facial aesthetics industry, and plans to rapidly expand the LABB brand to 20 locations by 2018. Financial projections estimate each LABB chair can generate $2-5 million in annual revenue given industry-leading margins and repeat customer rates.
This investor presentation provides an overview of Osisko Development Corp.'s plans to revive historical mining camps in North America. It discusses the results of a feasibility study for the Cariboo gold project in central British Columbia, which indicates it could be a large, long-lived, profitable mine. However, it notes the study includes various assumptions, uncertainties and risks that could materially affect results. It also discusses exploration results for the Trixie area that aim to expand resources but may not accurately predict mineralization. The presentation cautions investors that actual results may differ from expectations.
From idea to IPO: How an ISV can achieve growth and success within the Salesforce ecosystem
On July 14th, 2020, nCino rang the opening bell and became a publicly-traded company. To both thrive as a Salesforce ISV and accomplish something as impressive as an IPO requires getting many things right.
Brian Walsh, CodeScience CEO, sits down with Trisha Price, nCino CPO, to have an open conversation of how nCino got things right and share what ISVs can do today to set themselves up for success.
In this webinar, you’ll learn:
- How your customer needs can drive your product strategy
- Why company culture is a core differentiator and a lever of success for nCino
- What it takes to create meaningful relationships at Salesforce as an ISV
Don’t miss this opportunity to learn how you can create a business on Salesforce that thrives.
This investor presentation provides an overview of Fortune Minerals Limited and its mining projects. It summarizes the company's plans to complete the acquisition of the Revenue Silver Mine and ramp up production. It also outlines the anticipated economics, costs, and timelines for developing the NICO cobalt-gold-bismuth-copper project and Saskatchewan metals processing plant. However, it notes that the presentation contains forward-looking information that is subject to risks and uncertainties that could cause actual results to differ from expectations. All scientific and technical information is based on previous technical reports filed with SEDAR.
Fortune Minerals presented information on its key assets - the Revenue Silver Mine, NICO Project, and Arctos Anthracite Project. The Revenue Silver Mine in Colorado is a producing mine ramping up to 400 tons per day with historical production of 15 million ounces of silver. The NICO Project in the Northwest Territories has over 1 million ounces of gold plus cobalt, bismuth, and copper resources. It has completed feasibility studies and environmental assessments. The Arctos Project in British Columbia has a world-class metallurgical coal deposit and completed a positive feasibility study, with environmental assessment in progress. Fortune aims to become a multi-asset producer once NICO enters production, with combined revenues forecast at over $
- Ero Copper is a high-growth clean copper producer with operations in Brazil focused on organic growth and strong returns.
- The company's portfolio includes the long-life MCSA Mining Complex, the NX Gold Mine, and the Boa Esperança project currently under construction, with a track record of doubling copper production every 4 years through exploration success and low-cost expansions.
- Ero Copper aims to continue outperforming peers through its high-quality assets in a mining-friendly jurisdiction, strong balance sheet, and aligned management team focused on returns.
- Ero Copper is a Brazil-focused clean copper producer with meaningful gold production and strong exploration focus driving organic growth.
- The company has a high-quality portfolio in Brazil including the MCSA Mining Complex, NX Gold Mine, and Boa Esperança development project, which is expected to double copper production every 4 years.
- Ero Copper has a strong track record of returns driven by a focus on return on invested capital, peer-leading organic growth with low capital intensity, and balance sheet strength for resilience.
KWESST develops and commercializes proprietary next-generation technologies that deliver a tactical advantage for military, security forces, and personal defense. The Company focuses on three niche segments including non-lethal products for personal defense, public safety, and realistic training, digitization for real-time situational awareness and targeting for ground forces, and counter-threat protection against lasers, electronic detection, and hostile drones.
Ero Copper provides an investor presentation highlighting its status as a Brazil-focused clean copper producer with meaningful gold production and fully-funded organic growth driven by exploration. The company has industry-leading returns with a 43% last twelve months return on invested capital and plans to double its copper production every four years. Ero operates in Brazil, which has one of the cleanest electricity grids in the world sourcing 85% of power from renewable sources such as hydropower, wind, and solar.
Osisko Development - Investor Presentation - Jan 24Philip Rabenok
Osisko Development Corp. is a North American gold mining company that presented an investor presentation in January 2024. The presentation provides forward-looking statements regarding the company's Cariboo gold project, including expectations that it will be a large-scale, long-life and profitable mine based on preliminary economic assessments. However, the presentation also notes that all forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from expectations. Non-IFRS measures are used to provide an alternative view to evaluate the company's performance.
CrowdStrike April 2023 Investor Briefing Presentation.pdfJohnBaleini
- George Kurtz, Co-Founder and CEO of CrowdStrike, presented at an investor briefing in April 2023 on the CrowdStrike Falcon platform and its advantages over legacy antivirus solutions and Microsoft.
- The CrowdStrike Falcon platform is a modern XDR platform that utilizes AI and a cloud-native architecture to stop breaches by providing better endpoint protection, threat intelligence, and security operations than signature-based antivirus products.
- CrowdStrike has gained significant market share leadership with its Falcon platform and is ranked #1 in the IDC report on the modern endpoint security market, with 8 out of 10 enterprise customers choosing CrowdStrike over Microsoft when tested.
KWESST develops and commercializes proprietary next-generation technologies that deliver a tactical advantage for military, security forces, and personal defense. The Company focuses on three niche segments including non-lethal products for personal defense, public safety, and realistic training, digitization for real-time situational awareness and targeting for ground forces, and counter-threat protection against lasers, electronic detection, and hostile drones.
- Ero Copper is a high-growth clean copper producer with operations in Brazil focused on organic growth and strong returns.
- Production is expected to double every 4 years from 20,000 tonnes in 2017 to 46,000 tonnes in 2021 and 97,000 tonnes by 2025 through projects like the new Boa Esperança mine.
- The company has a high quality portfolio of low-cost assets in Brazil with a focus on exploration driving further growth and returns.
Second Quarter Fiscal 2019 STZ Investor Overview Presentationconstellationbrands
This document provides an overview of Constellation Brands' investment in Canopy Growth Corporation and the cannabis market opportunity. It discusses Constellation's goal of building a single global cannabis platform to address all markets and formats to succeed in this complex, rapidly evolving industry expected to grow to over $200 billion globally within 15 years. The summary highlights Constellation's view that cannabis will demonstrate similar category dynamics to total beverage alcohol, playing to its strengths.
ODV - Investor Presentation - February 2024Philip Rabenok
This investor presentation from Osisko Development Corp provides an overview of the company as a premier North American gold mining company. It cautions readers that portions of the presentation contain forward-looking statements regarding future plans and expectations that are based on certain assumptions and are subject to risks and uncertainties. These forward-looking statements include projections for production capacity, mine plans, processing expectations, permitting timelines, infrastructure assumptions, and estimates for capital and operating costs. The presentation also provides non-IFRS financial measures and ratios to evaluate the company's performance and cautions that these measures may not be comparable to those used by other companies.
The document provides forward-looking statements and cautionary notes regarding Osisko Gold Royalties' full year and Q4 2023 results. It summarizes that Osisko earned a record 94,323 gold equivalent ounces in 2023, up from 89,367 ounces in 2022. It also notes that the document contains forward-looking production estimates and guidance for 2024-2028 based on disclosure from operators of properties in Osisko's portfolio. The document cautions that several risk factors could cause actual results to differ from forward-looking statements and that Osisko relies on public disclosures from other issuers and third parties regarding its assets.
Osisko's senior-quality portfolio includes 19 producing assets anchored by a 5% NSR royalty on Agnico Eagle's Canadian Malartic Complex, one of Canada's largest gold mines. The portfolio has peer-leading organic growth potential with attributable GEO delivery growth of ~30% expected by 2028 based on Osisko's 5-year outlook. Over 75% of Osisko's assets are located in low-risk Tier 1 mining jurisdictions like Canada and the US.
This document discusses Osisko Gold Royalties' senior-quality precious metal portfolio, leading growth potential, and 2024 guidance. It highlights Osisko's 19 producing assets anchored by a 5% royalty on Agnico Eagle's Canadian Malartic mine. It also notes Osisko's peer-leading organic growth profile with 30% expected growth in attributable gold equivalent ounces by 2028 based on its 5-year outlook. Additionally, it states that Osisko has the highest concentration of assets in low-risk Tier 1 mining jurisdictions.
This document is an investor presentation by Osisko Development Corp, a North American gold mining company. It provides an overview of the company, including descriptions of its key projects in Canada and the United States, and cautions readers about forward-looking statements in the presentation by noting numerous risks and uncertainties that could affect the company's projections. It also references technical reports that provide details on mineral resource estimates for the company's projects.
This investor presentation provides an overview of Fortune Minerals Limited and its mining projects. It summarizes the company's plans to complete the acquisition of the Revenue Silver Mine and ramp up production. It also outlines the anticipated economics, costs, and timelines for developing the NICO cobalt-gold-bismuth-copper project and Saskatchewan metals processing plant. However, it notes that the presentation contains forward-looking information that is subject to risks and uncertainties that could cause actual results to differ from expectations. All scientific and technical information is based on previous technical reports filed with SEDAR.
Fortune Minerals presented information on its key assets - the Revenue Silver Mine, NICO Project, and Arctos Anthracite Project. The Revenue Silver Mine in Colorado is a producing mine ramping up to 400 tons per day with historical production of 15 million ounces of silver. The NICO Project in the Northwest Territories has over 1 million ounces of gold plus cobalt, bismuth, and copper resources. It has completed feasibility studies and environmental assessments. The Arctos Project in British Columbia has a world-class metallurgical coal deposit and completed a positive feasibility study, with environmental assessment in progress. Fortune aims to become a multi-asset producer once NICO enters production, with combined revenues forecast at over $
- Ero Copper is a high-growth clean copper producer with operations in Brazil focused on organic growth and strong returns.
- The company's portfolio includes the long-life MCSA Mining Complex, the NX Gold Mine, and the Boa Esperança project currently under construction, with a track record of doubling copper production every 4 years through exploration success and low-cost expansions.
- Ero Copper aims to continue outperforming peers through its high-quality assets in a mining-friendly jurisdiction, strong balance sheet, and aligned management team focused on returns.
- Ero Copper is a Brazil-focused clean copper producer with meaningful gold production and strong exploration focus driving organic growth.
- The company has a high-quality portfolio in Brazil including the MCSA Mining Complex, NX Gold Mine, and Boa Esperança development project, which is expected to double copper production every 4 years.
- Ero Copper has a strong track record of returns driven by a focus on return on invested capital, peer-leading organic growth with low capital intensity, and balance sheet strength for resilience.
KWESST develops and commercializes proprietary next-generation technologies that deliver a tactical advantage for military, security forces, and personal defense. The Company focuses on three niche segments including non-lethal products for personal defense, public safety, and realistic training, digitization for real-time situational awareness and targeting for ground forces, and counter-threat protection against lasers, electronic detection, and hostile drones.
Ero Copper provides an investor presentation highlighting its status as a Brazil-focused clean copper producer with meaningful gold production and fully-funded organic growth driven by exploration. The company has industry-leading returns with a 43% last twelve months return on invested capital and plans to double its copper production every four years. Ero operates in Brazil, which has one of the cleanest electricity grids in the world sourcing 85% of power from renewable sources such as hydropower, wind, and solar.
Osisko Development - Investor Presentation - Jan 24Philip Rabenok
Osisko Development Corp. is a North American gold mining company that presented an investor presentation in January 2024. The presentation provides forward-looking statements regarding the company's Cariboo gold project, including expectations that it will be a large-scale, long-life and profitable mine based on preliminary economic assessments. However, the presentation also notes that all forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from expectations. Non-IFRS measures are used to provide an alternative view to evaluate the company's performance.
CrowdStrike April 2023 Investor Briefing Presentation.pdfJohnBaleini
- George Kurtz, Co-Founder and CEO of CrowdStrike, presented at an investor briefing in April 2023 on the CrowdStrike Falcon platform and its advantages over legacy antivirus solutions and Microsoft.
- The CrowdStrike Falcon platform is a modern XDR platform that utilizes AI and a cloud-native architecture to stop breaches by providing better endpoint protection, threat intelligence, and security operations than signature-based antivirus products.
- CrowdStrike has gained significant market share leadership with its Falcon platform and is ranked #1 in the IDC report on the modern endpoint security market, with 8 out of 10 enterprise customers choosing CrowdStrike over Microsoft when tested.
KWESST develops and commercializes proprietary next-generation technologies that deliver a tactical advantage for military, security forces, and personal defense. The Company focuses on three niche segments including non-lethal products for personal defense, public safety, and realistic training, digitization for real-time situational awareness and targeting for ground forces, and counter-threat protection against lasers, electronic detection, and hostile drones.
- Ero Copper is a high-growth clean copper producer with operations in Brazil focused on organic growth and strong returns.
- Production is expected to double every 4 years from 20,000 tonnes in 2017 to 46,000 tonnes in 2021 and 97,000 tonnes by 2025 through projects like the new Boa Esperança mine.
- The company has a high quality portfolio of low-cost assets in Brazil with a focus on exploration driving further growth and returns.
Second Quarter Fiscal 2019 STZ Investor Overview Presentationconstellationbrands
This document provides an overview of Constellation Brands' investment in Canopy Growth Corporation and the cannabis market opportunity. It discusses Constellation's goal of building a single global cannabis platform to address all markets and formats to succeed in this complex, rapidly evolving industry expected to grow to over $200 billion globally within 15 years. The summary highlights Constellation's view that cannabis will demonstrate similar category dynamics to total beverage alcohol, playing to its strengths.
ODV - Investor Presentation - February 2024Philip Rabenok
This investor presentation from Osisko Development Corp provides an overview of the company as a premier North American gold mining company. It cautions readers that portions of the presentation contain forward-looking statements regarding future plans and expectations that are based on certain assumptions and are subject to risks and uncertainties. These forward-looking statements include projections for production capacity, mine plans, processing expectations, permitting timelines, infrastructure assumptions, and estimates for capital and operating costs. The presentation also provides non-IFRS financial measures and ratios to evaluate the company's performance and cautions that these measures may not be comparable to those used by other companies.
The document provides forward-looking statements and cautionary notes regarding Osisko Gold Royalties' full year and Q4 2023 results. It summarizes that Osisko earned a record 94,323 gold equivalent ounces in 2023, up from 89,367 ounces in 2022. It also notes that the document contains forward-looking production estimates and guidance for 2024-2028 based on disclosure from operators of properties in Osisko's portfolio. The document cautions that several risk factors could cause actual results to differ from forward-looking statements and that Osisko relies on public disclosures from other issuers and third parties regarding its assets.
Osisko's senior-quality portfolio includes 19 producing assets anchored by a 5% NSR royalty on Agnico Eagle's Canadian Malartic Complex, one of Canada's largest gold mines. The portfolio has peer-leading organic growth potential with attributable GEO delivery growth of ~30% expected by 2028 based on Osisko's 5-year outlook. Over 75% of Osisko's assets are located in low-risk Tier 1 mining jurisdictions like Canada and the US.
This document discusses Osisko Gold Royalties' senior-quality precious metal portfolio, leading growth potential, and 2024 guidance. It highlights Osisko's 19 producing assets anchored by a 5% royalty on Agnico Eagle's Canadian Malartic mine. It also notes Osisko's peer-leading organic growth profile with 30% expected growth in attributable gold equivalent ounces by 2028 based on its 5-year outlook. Additionally, it states that Osisko has the highest concentration of assets in low-risk Tier 1 mining jurisdictions.
This document is an investor presentation by Osisko Development Corp, a North American gold mining company. It provides an overview of the company, including descriptions of its key projects in Canada and the United States, and cautions readers about forward-looking statements in the presentation by noting numerous risks and uncertainties that could affect the company's projections. It also references technical reports that provide details on mineral resource estimates for the company's projects.
